Marshall Wace, LLP Effector Therapeutics Inc Transaction History
Marshall Wace, LLP
- $72.2 Billion
- Q2 2024
A detailed history of Marshall Wace, LLP transactions in Effector Therapeutics Inc stock. As of the latest transaction made, Marshall Wace, LLP holds 16,661 shares of EFTRW stock, worth $0. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,661Holding current value
$0% of portfolio
0.0%Shares
0 transactions
Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
---|
Others Institutions Holding EFTRW
# of Institutions
17Shares Held
2.85MCall Options Held
72.7KPut Options Held
0-
Aristeia Capital LLC Greenwich, CT1.3MShares$00.0% of portfolio
-
Goldman Sachs Group Inc New York, NY631KShares$00.0% of portfolio
-
Whitebox Advisors LLC Minneapolis, MN298KShares$00.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA201KShares$00.0% of portfolio
-
Mmcap International Inc. Spc Grand Cayman, E9146KShares$00.0% of portfolio